An investigation to establish the practical approach for diagnosis of wild-type transthyretin cardiac amyloidosis
Not Applicable
Recruiting
- Conditions
- wild-type transthyretin cardiac amyloidosis
- Registration Number
- JPRN-UMIN000044021
- Lead Sponsor
- Kochi Medical School, Kochi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1142
Inclusion Criteria
Not provided
Exclusion Criteria
patients with hemodialysis, patients with history of heart failure hospitalization
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie wild-type transthyretin cardiac amyloidosis progression and potential therapeutic targets?
How does the diagnostic approach in JPRN-UMIN000044021 compare to standard-of-care methods for ATTR-CM detection?
Which biomarkers are most predictive for early diagnosis and prognosis in wild-type transthyretin cardiac amyloidosis?
What adverse events are commonly associated with current ATTR-CM diagnostic imaging techniques and how are they managed?
Are there any emerging therapies or combination strategies targeting TTR misfolding in cardiac amyloidosis?